Mondorf A W, Scherberich J E, Reitinger W
Contrib Nephrol. 1975;1:119-25.
In urine concentrates form patients with acute and chronic glomerulonephritis and patients under cytostatic treatment, remarkable amounts of membrane-bound alanine-aminopeptidase, alkaline-phosphatase and gamma-glutamyltraspeptidase could be recognized. With an anti-brush-border antisera membrane-bound enzymes could be differentiated from soluble fractions of other origins. Patients with recognizable membrane proteins in urine showed tendencies toward progression of their kidney diseases. Patients under cytostatic treatment with high dose showed a very early output of these enzymes while others under low dose started after a longer treatment with the excretion of membrane-bound enzymes.
在急性和慢性肾小球肾炎患者以及接受细胞抑制治疗的患者的尿液浓缩物中,可以识别出大量的膜结合丙氨酸氨基肽酶、碱性磷酸酶和γ-谷氨酰转肽酶。使用抗刷状缘抗血清,可以将膜结合酶与其他来源的可溶性部分区分开来。尿液中可识别膜蛋白的患者显示出肾脏疾病进展的趋势。高剂量细胞抑制治疗的患者这些酶的排出非常早,而低剂量治疗的其他患者在较长时间治疗后才开始排出膜结合酶。